Literature DB >> 15046631

Effect of modified ultrafiltration on inflammatory mediators, coagulation factors, and other proteins in blood after an extracorporeal circuit.

Masanori Fujita1, Masayuki Ishihara, Yoshimasa Kusama, Masafumi Shimizu, Tamizo Kimura, Yasuhiro Iizuka, Shigeyuki Ozaki, Masato Muraoka, Yuji Morimoto, Shigeto Takeshima, Makoto Kikuchi, Tadaaki Maehara.   

Abstract

Modified ultrafiltration (MUF) is a technique able to remove the excess body fluid and inflammatory mediators associated with the use of a cardiopulmonary bypass (CPB). It has been shown to reduce morbidity after cardiac operations in children. Application of MUF after adult cardiac operations has also been suggested being associated with a lower prevalence of early morbidity. However, the relationship between the concentration of mediators in the blood and postoperative morbidity remains yet to be proved. In this study, changes of various chemical mediators in the filtrate and blood before and after MUF have been evaluated in adult patients. Significant reductions of blood levels of inflammatory cytokines were not observed after MUF. On the other hand, MUF significantly elevated hematocrit, number of red cells, concentrations of albumine, coagulation Factor VII and X, platelet factor (PF)-4, and antithrombin (AT-) III.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15046631     DOI: 10.1111/j.1525-1594.2004.47230.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  8 in total

1.  Use of the Quest Myocardial Protection System (MPS) for modified ultrafiltration during pediatric cardiac surgery.

Authors:  Cody C Trowbridge; Alfred H Stammers; Myra H Klayman; James D Murdock; Bianca R Yen; Christian L Gilbert
Journal:  J Extra Corpor Technol       Date:  2005-06

2.  Effects of modified ultrafiltration on coagulation as measured by the thromboelastograph.

Authors:  Thomas G Steffens; Takushi Kohmoto; Niloo Edwards; Richard L Wolman; David W Holt
Journal:  J Extra Corpor Technol       Date:  2008-12

3.  First-stage angioplasty for a single ventricle with pulmonary artery coarctation.

Authors:  Shin Takabayashi; Hideto Shimpo; Kazuto Yokoyama; Masaki Kajimoto; Yoshihide Mitani; Hideki Iwata
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-11

4.  Relationship between increased blood pressure and hematocrit during modified ultrafiltration for pediatric open heart surgery.

Authors:  Shin Takabayashi; Hideto Shimpo; Kazuto Yokoyama; Hideki Iwata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-01

5.  Continuous monitoring of inflammation biomarkers during simulated cardiopulmonary bypass using a microfluidic immunoassay device - a pilot study.

Authors:  Lawrence A Sasso; Kiana Aran; Yulong Guan; Akif Ündar; Jeffrey D Zahn
Journal:  Artif Organs       Date:  2013-01       Impact factor: 3.094

6.  Venoarterial modified ultrafiltration versus conventional arteriovenous modified ultrafiltration during cardiopulmonary bypass surgery.

Authors:  Rakesh Mohanlall; Jamila Adam; Arto Nemlander
Journal:  Ann Saudi Med       Date:  2014 Jan-Feb       Impact factor: 1.526

7.  Modified ultrafiltration reduces postoperative blood loss and transfusions in adult cardiac surgery: a meta-analysis of randomized controlled trials.

Authors:  Zhao Kai Low; Fei Gao; Kenny Yoong Kong Sin; Kok Hooi Yap
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-10

8.  Effect of modified ultrafiltration on cytokines and hemoconcentration in dogs undergoing cardiopulmonary bypass.

Authors:  Haruhiko Suzuki; Naoko Oshima; Toshihiro Watari
Journal:  J Vet Med Sci       Date:  2020-10-05       Impact factor: 1.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.